ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Protocol ID
BIOMEDE
Condition/s
Diffuse Intrinsic Pontine Glioma (DIPG)
Diagnosis Stage
New diagnosis
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Collaborators
Innovative Therapies For Children with Cancer Consortium
Links
External Registry ≫
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 2
Age Eligibility
6 months to 25 years
International registry ID's
NCT02233049
Back to Registry
Study Title BIOMEDE: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Protocol ID BIOMEDE
Disease (Sub Disease) Diffuse Intrinsic Pontine Glioma (DIPG)
Diagnosis Stage New diagnosis
Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Collaborators Innovative Therapies For Children with Cancer Consortium
Links https://clinicaltrials.gov/ct2/show/NCT02233049
Trial Status Closed to Recruitment
Trial Open Date 31/07/2018
Study Type Treatment
Phase Phase 2
Age Eligibility 6 months to 25 years
International registry ID's NCT02233049

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.